Alpna Seth

Insider Reports History

Entity
Individual
Location
614 Mckinley Place Ne, Minneapolis, MN
Signature
/s/ Keith Regnante, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alpna Seth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIO-TECHNE Corp Director Common Stock 12.3K $953K $77.42 Oct 26, 2023 Direct
Keros Therapeutics, Inc. Director Stock Option (right to buy) 10K May 30, 2024 Direct
BIO-TECHNE Corp Director Stock Options (Right to Buy) 3.94K Oct 26, 2023 Direct
Seagen Inc. Director Common Stock 0 $229.00 Dec 14, 2023 Direct
Seagen Inc. Director Restricted Stock Units 0 $229.00 Dec 14, 2023 Direct
Seagen Inc. Director Stock Options (Right to Buy) 0 Dec 14, 2023 Direct

Insider Reports Filed by Alpna Seth

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KROS Keros Therapeutics, Inc. May 30, 2024 1 $0 4 Jun 3, 2024 Director
SGEN Seagen Inc. Dec 14, 2023 7 -$2.97M 4 Dec 15, 2023 Director
TECH BIO-TECHNE Corp Oct 26, 2023 2 $0 4 Oct 30, 2023 Director
KROS Keros Therapeutics, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
SGEN Seagen Inc. May 31, 2023 1 $0 4 Jun 2, 2023 Director
KROS Keros Therapeutics, Inc. May 1, 2023 1 $0 4 May 3, 2023 Director
KROS Keros Therapeutics, Inc. May 1, 2023 0 $0 3 May 3, 2023 Director
TECH BIO-TECHNE Corp Oct 27, 2022 2 $0 4 Oct 31, 2022 Director
SGEN Seagen Inc. May 13, 2022 2 $0 4 May 17, 2022 Director
TECH BIO-TECHNE Corp Oct 28, 2021 2 $0 4 Nov 1, 2021 Director
SGEN Seagen Inc. May 14, 2021 2 $0 4 May 18, 2021 Director